scholarly journals Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers

Oncotarget ◽  
2017 ◽  
Vol 8 (49) ◽  
pp. 85692-85715 ◽  
Author(s):  
Akram Mohammed ◽  
Greyson Biegert ◽  
Jiri Adamec ◽  
Tomáš Helikar
Nature ◽  
2020 ◽  
Vol 579 (7797) ◽  
pp. 130-135 ◽  
Author(s):  
John Alec Moral ◽  
Joanne Leung ◽  
Luis A. Rojas ◽  
Jennifer Ruan ◽  
Julia Zhao ◽  
...  

2014 ◽  
Author(s):  
Valentina Agoni

Some genes have ubiquitous expression patterns in an individual's cells, thus a paradox exists whereby mutations in such genes are only strongly associated with cancers of specific tissues. As these genes are ubiquitously expressed in the body's cells and thereby have functions in -potentially- all tissue types, then surely their resulting defects would manifest as cancers in all tissues? We hypothesize that the different susceptibility to mutations could explain the ‘tissue-specific’ paradox for cancer.


2000 ◽  
Vol 29 (3) ◽  
pp. 240-255 ◽  
Author(s):  
Wun-Shaing W. Chang ◽  
Nien-Tzu Chang ◽  
Sheng-Chieh Lin ◽  
Cheng-Wen Wu ◽  
Felicia Y.-H. Wu

2012 ◽  
Vol 39 (12) ◽  
pp. 11061-11072 ◽  
Author(s):  
Noel Pabalan ◽  
Ofelia Francisco-Pabalan ◽  
Hamdi Jarjanazi ◽  
Hong Li ◽  
Lillian Sung ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (13) ◽  
pp. 3194
Author(s):  
Daniela Iannazzo ◽  
Claudia Espro ◽  
Consuelo Celesti ◽  
Angelo Ferlazzo ◽  
Giovanni Neri

The timely diagnosis of cancer represents the best chance to increase treatment success and to reduce cancer deaths. Nanomaterials-based biosensors containing graphene quantum dots (GQDs) as a sensing platform show great promise in the early and sensitive detection of cancer biomarkers, due to their unique chemical and physical properties, large surface area and ease of functionalization with different biomolecules able to recognize relevant cancer biomarkers. In this review, we report different advanced strategies for the synthesis and functionalization of GQDs with different agents able to selectively recognize and convert into a signal specific cancer biomarkers such as antigens, enzymes, hormones, proteins, cancer related byproducts, biomolecules exposed on the surface of cancer cells and changes in pH. The developed optical, electrochemical and chemiluminescent biosensors based on GQDs have been shown to ensure the effective diagnosis of several cancer diseases as well as the possibility to evaluate the effectiveness of anticancer therapy. The wide linear range of detection and low detection limits recorded for most of the reported biosensors highlight their great potential in clinics for the diagnosis and management of cancer.


Sign in / Sign up

Export Citation Format

Share Document